Introduction: Around 20% of patients attending general practice are smokers. Information on their preferences and experiences can guide health professionals providing cessation support.Aim: To describe previous quit attempts and smoking cessation preferences of smokers recruited within a cluster randomised controlled trial.Methods: Patients aged ≥40 years, with ≥10 pack year history of smoking, were recruited from 39 general practice clinics across Melbourne, Australia. A structured questionnaire and exhaled carbon monoxide (CO) test were completed during a patient interview.Results: Of 526 smokers recruited, 491 (93%) smoked daily. The median exhaled CO was 22 ppm (IQR 14-29). 278 (53%) smokers had attempted quitting in the last year. Common pharmacotherapies used were nicotine replacement therapy (155, 58%) and varenicline (84, 30%). Hypnotherapy (44, 16%) was the most popular non-pharmacological option. E-cigarettes were used by 30 (11%). Previous side effects from pharmacotherapies were reported by 146 (28%) smokers. Around half of smokers previously experienced difficulties in quitting, such as irritability/aggression and urges to smoke. Preference for using medications in future quit attempts was stated by 205 (39%) smokers; one-third would consider using e-cigarettes.Conclusion: Non-evidence-based smoking cessation aids are used by smokers in primary care. Health professionals could enhance smoking cessation support in primary care by recommending evidence-based treatments and close monitoring of those experiencing difficulties or side effects during quit attempts.
|Number of pages||1|
|Journal||Eur Respir J|
|Issue number||Suppl 61|
|Publication status||Published - 1 Sep 2017|